DPHARMA | CCM DUOPHARMA BIOTECH BHD*
1.40 (0.72%)
Last updated: 17:00
iSaham Fundamental Trend - DPHARMA
FCON: 0.64 | Sharpe Ratio: 0.71 | LTS: 8.09
Financial Ratios - DPHARMA
| EPS | 8.63 sen |
| Trailing PE (Sector Median: 14.1) | 16.1 |
| PEG | -2.48 |
| Altman Z | 1.3 |
| Beaver | 0.023 |
| Current Ratio | 1.63 |
| Debt-Equity (DE) Ratio | 0.81 |
| FCF Yield | -2.1 % |
| Dividend Per Share (DPS) | 5.0 sen |
| Revenue QoQ | 13.52 % |
| Revenue YoY | 11.91 % |
| Profit QoQ | 20.94 % |
| Profit YoY | 27.24 % |
| NTA QoQ | -1.32 % |
| Profit Margin (Sector Median: 5.3) | 10.39 % |
| ROE | 10.93 % |
| ROIC | 8.68 % |
| Dividend Yield (DY) | 3.57 % |
Support & Resistance
ATR Trailing Stop: 1.35
| Price | 1.35 | 1.36 | 1.37 | 1.38 | 1.4 | 1.4 | 1.4 | 1.41 | 1.42 | 1.43 | 1.44 |
| Volume (M) | 31.3 | 34.7 | 37.1 | 37.1 | 38.7 | 38.7 | 31.8 | 9.9 | 18.8 | 8.3 | |
Gann Support (EP/CL): 1.39/1.33 | Resistance (TP): 1.45/1.51
*Highlighted column shows significant volume at the support or resistance area.
Technical Trend
Moving Average Trend
Volume Trend
Trading Signalsbeta - DPHARMA
Based on iSaham Screeners
| Moving Average (Short Term) | BUY |
| Moving Average (Mid Term) | BUY |
| Moving Average (Long Term) | BUY |
| Ichimoku Kumo | HOLD |
| Bollinger Band | BUY (Breakout) |
| RSI | BUY |
| Stochastic | BUY |
| Heikin-Ashi | BUY |
| MACD | BUY (4R1G+MA20) |
| Solid MA Trend | BUY |
| SAT | HOLD |
| Sector Trend (Long Term) | SELL |
| Sector Trend (Short Term) | SELL |
| Institutional Holdings | BUY |
| Beat The Insti | BUY |
| Magic Formula | - |
| Better Than ASB | - |
| 52-Week High | - |
| BTST | - |
| T+ | - |
| Candlestick | - |
| Chart Pattern | - |
Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.
Fair Value
iSaham Fair Value: 0.71
| Discounted Cash Flow (DCF)5.0% Growth | 0.71 |
| Discounted Cash Flow (DCF)-2.8% Growth | 0.41 |
| Relative Valuation | 1.23 |
| Graham Formula | 0.65 |
| Graham Number | 0.0 |
| Net Tangible Asset (NTA) | 0.75 |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 138.29 |
| Expected Revenue (M) | 1331.0 |
| Expected Growth (%) | 18.0 |
Summary
Market Cap: 925 M.
Number of Shares: 661 M.
Float: 40.43%.
Stock highly correlated with
SUCCESS (88%)
BJTOTO (82%)
SUNCON (80%)
HOHUP (78%)
CCM Duopharma Biotech Berhad, an investment holding company, is engaged in the manufacture, distribution, import, and export of pharmaceutical products and medicines in Malaysia. It offers various over the-counter products, including oral antibiotics, cough syrups, analgesic/anti-pyretics, anti-bacterial mouthwash, children's vitamins, haemodialysis solutions, dental cartridges, and eye drop preparations. The company exports its products to various countries, including Vietnam, Ethiopia, Sudan, Southeast Asia, Papua New Guinea, Pakistan, Bangladesh, Sri Lanka, Republic of Yemen, Singapore, and Hong Kong. Founded in 1979, the company is based in Klang, Malaysia. CCM Duopharma Biotech Berhad is a subsidiary of CCM Marketing Sdn. Bhd.
Code: 7148
Website: http://duopharmabiotech.com/
Related Links: Bursa | Annual Report | Announcement
AGM Doorgift: Pharmacy Products + RM10 TnG (2019) | AGM Announcement
Top Shareholdings
Updated on 29-Mar-2019
| Shareholder | Value (M) |
|---|---|
| Permodalan Nasional Berhad | 418.71 |
| Employees Provident Fund Board | 58.07 |
| Amanah Saham Bumiputera | 35.0 |
| Billion Victory Sdn. Bhd. | 23.91 |
| Employees Provident Fund Board | 14.32 |
| Amanah Saham Malaysia | 14.0 |
| Public Islamic Treasures Growth Fund | 9.77 |
| Credit Suisse | 8.48 |
| CIMB Islamic Dali Equity Theme Fund | 6.47 |
| Tokio Marine Life Insurance Malaysia Bhd | 6.27 |
| Kumpulan Wang Persaraan (Diperbadankan) | 6.05 |
| Kumpulan Wang Persaraan (Diperbadankan) | 4.88 |
| Kaf Dana Adib | 4.59 |
| Manulife Investment Progress Fund | 4.28 |
| CIMB Islamic Small Cap Fund | 4.28 |
| Amanah Saham Malaysia 3 | 4.19 |
| National Trust Fund | 3.87 |
| Affin Hwang Principled Growth Fund | 3.45 |
| Leong Chao Seong | 3.4 |
| CIMB-Principal Small Cap Fund | 3.35 |
| Amtotal Return | 3.3 |
| Kaf Tactical Fund | 3.09 |
| Ooi Keng Tan | 2.96 |
| CIMB Islamic Trustee Berhad - Kenanga Syariah Growth Fund | 2.74 |
| Gibraltar BSN Aggressive Fund | 2.67 |
| Wong Kin Wah | 2.32 |